Cargando…

Subjective Overview of Accelerated Aging in Schizophrenia

Schizophrenia, like many other human diseases, particularly neuropsychiatric diseases, shows evidence of accelerated brain aging. The molecular nature of the process of aging is unknown but several potential indicators have been used in research. The concept of accelerated aging in schizophrenia too...

Descripción completa

Detalles Bibliográficos
Autor principal: Seeman, Mary V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9819113/
https://www.ncbi.nlm.nih.gov/pubmed/36613059
http://dx.doi.org/10.3390/ijerph20010737
_version_ 1784865151263965184
author Seeman, Mary V.
author_facet Seeman, Mary V.
author_sort Seeman, Mary V.
collection PubMed
description Schizophrenia, like many other human diseases, particularly neuropsychiatric diseases, shows evidence of accelerated brain aging. The molecular nature of the process of aging is unknown but several potential indicators have been used in research. The concept of accelerated aging in schizophrenia took hold in 2008 and its timing, pace, determinants and deterrents have been increasingly examined since. The present overview of the field is brief and selective, based on diverse studies, expert opinions and successive reviews. Current thinking is that the timing of age acceleration in schizophrenia can occur at different time periods of the lifespan in different individuals, and that antipsychotics may be preventive. The majority opinion is that the cognitive decline and premature death often seen in schizophrenia are, in principle, preventable.
format Online
Article
Text
id pubmed-9819113
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98191132023-01-07 Subjective Overview of Accelerated Aging in Schizophrenia Seeman, Mary V. Int J Environ Res Public Health Review Schizophrenia, like many other human diseases, particularly neuropsychiatric diseases, shows evidence of accelerated brain aging. The molecular nature of the process of aging is unknown but several potential indicators have been used in research. The concept of accelerated aging in schizophrenia took hold in 2008 and its timing, pace, determinants and deterrents have been increasingly examined since. The present overview of the field is brief and selective, based on diverse studies, expert opinions and successive reviews. Current thinking is that the timing of age acceleration in schizophrenia can occur at different time periods of the lifespan in different individuals, and that antipsychotics may be preventive. The majority opinion is that the cognitive decline and premature death often seen in schizophrenia are, in principle, preventable. MDPI 2022-12-31 /pmc/articles/PMC9819113/ /pubmed/36613059 http://dx.doi.org/10.3390/ijerph20010737 Text en © 2022 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Seeman, Mary V.
Subjective Overview of Accelerated Aging in Schizophrenia
title Subjective Overview of Accelerated Aging in Schizophrenia
title_full Subjective Overview of Accelerated Aging in Schizophrenia
title_fullStr Subjective Overview of Accelerated Aging in Schizophrenia
title_full_unstemmed Subjective Overview of Accelerated Aging in Schizophrenia
title_short Subjective Overview of Accelerated Aging in Schizophrenia
title_sort subjective overview of accelerated aging in schizophrenia
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9819113/
https://www.ncbi.nlm.nih.gov/pubmed/36613059
http://dx.doi.org/10.3390/ijerph20010737
work_keys_str_mv AT seemanmaryv subjectiveoverviewofacceleratedaginginschizophrenia